Stockreport

4D Molecular Therapeutics: Jury Still Out On CF Gene Therapy After Dense Data Drop [Seeking Alpha]

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF The recent Otsuka partnership secures $85M upfront, cost sharing, and milestones, extending FDMT's cash runway into 2028 and supporting global development. 4D-710's e [Read more]